Author: admin

Collaboration Tool Market to Hit $84.10 Billion By 2034 | Empowering teams to collaborate, innovate, and succeed globally.

“Empowering teams with seamless connectivity and agile collaboration, the market redefines teamwork for a digital era”
Collaboration Tool Market is projected to grow from USD 28.17 Billion in 2025 to USD 84.10 Billion by 2034, exhibiting a compound annual growth rate (CAGR) of 12.92% during the forecast period (2025 – 2034). Additionally, the market size for Collaboration Tool Market was valued at USD 24.95 billion in 2024.

The Collaboration Tool Market is experiencing rapid growth driven by the increasing adoption of remote and hybrid work models, digital transformation, and the need for seamless communication across teams. These tools encompass a wide range of solutions, including video conferencing, project management, file sharing, and real-time messaging, catering to businesses of all sizes. The integration of AI, automation, and cloud-based platforms has further enhanced efficiency, productivity, and security within collaborative environments. Key players in the market include Microsoft, Slack, Zoom, Google, and Asana, among others. As organizations prioritize workforce connectivity and digital workflows, the demand for innovative and scalable collaboration solutions is expected to continue rising.

Market Key Players in the Collaboration Tool Market Industry

The Collaboration Tool Market is highly competitive, with several key players leading the charge in developing innovative communication solutions. Prominent companies in this space include,

  • Salesforce
  • Microsoft
  • Dropbox
  • Cisco
  • Smartsheet
  • Zoho
  • Wrike
  • Asana
  • Podio
  • Google
  • Basecamp
  • Slack
  • IBM
  • Trello
  • Zoom

 

The Collaboration Tool Market is dominated by key players such as Microsoft (Microsoft Teams), Slack (Salesforce), Zoom, Google (Google Workspace), Asana, Trello (Atlassian), Cisco (Webex), and Dropbox, among others. These companies offer a variety of solutions, including video conferencing, messaging, project management, and file sharing, catering to businesses of all sizes. Emerging players and startups are also introducing AI-driven and cloud-based innovations to enhance productivity and user experience. With increasing competition, market leaders continue to expand their features, integrate AI capabilities, and improve security to meet evolving business collaboration needs.

Get An Exclusive Sample of the Research Report at – https://www.marketresearchfuture.com/sample_request/26421

Market Segmentation of Collaboration Tool MarketThe Collaboration Tool Market is segmented based on deployment type, organization size, industry vertical, and functionality. By deployment, it is categorized into cloud-based and on-premises solutions, with cloud-based tools gaining higher adoption due to scalability and remote accessibility. Based on organization size, the market serves small & medium enterprises (SMEs) and large enterprises, each requiring tailored collaboration solutions. Industry-wise, key sectors adopting these tools include IT & telecom, BFSI, healthcare, education, retail, and manufacturing, among others. Functionality-wise, the market is segmented into video conferencing, team communication, project management, document collaboration, and workflow automation. This diverse segmentation highlights the widespread use of collaboration tools across various business needs and industries.

Key Drivers of the Collaboration Tool Market

The Collaboration Tool Market is driven by several key factors, including the rise of remote and hybrid work models, which has increased demand for seamless communication and teamwork solutions. The growing digital transformation across industries is also fueling adoption, as businesses seek to enhance productivity and efficiency. Advancements in cloud computing, AI, and automation are further improving collaboration tool capabilities, making them more intelligent and user-friendly. The need for secure and compliant collaboration platforms, especially in regulated industries like BFSI and healthcare, is another major driver. Additionally, the increasing emphasis on real-time collaboration, integration with enterprise software, and cost-effective communication solutions continues to propel market growth.

The Collaboration Tool Market Opportunities

The Collaboration Tool Market presents significant opportunities as businesses increasingly prioritize digital transformation and remote work solutions. Emerging technologies such as AI, machine learning, and augmented reality are creating avenues for enhanced user experiences and smarter collaboration platforms. Additionally, the integration of these tools with other enterprise systems offers scope for seamless workflow automation and data-driven insights. As organizations across various industries seek scalable, secure, and customizable solutions, there is a growing market for niche applications tailored to specific business needs, especially in sectors like healthcare, education, and manufacturing. This dynamic landscape not only fuels product innovation but also opens up new revenue streams for vendors and service providers worldwide.

Restraints and Challenges in the Collaboration Tool Market

The collaboration tool market faces several restraints that hinder its expansive growth. One of the primary challenges is market saturation, where an abundance of similar tools makes it difficult for new or existing products to distinguish themselves. Additionally, issues such as data security concerns, integration with legacy systems, and resistance to change within organizations add layers of complexity to adoption. These factors, combined with budget constraints and the high cost of continuous innovation, serve as significant restraints for companies looking to invest in or expand their collaborative offerings.

Moreover, the rapid evolution of technology and shifting work paradigms, such as the rise of remote and hybrid work models, present ongoing challenges. Companies must constantly update and secure their platforms to keep pace with user expectations and regulatory demands, which can strain resources. Furthermore, ensuring seamless interoperability between various software systems, accommodating diverse working styles across different time zones, and addressing scalability issues remain persistent hurdles that require robust strategies and significant investments.

Buy this Premium Research Report | Immediate Delivery Available at – https://www.marketresearchfuture.com/checkout?currency=one_user-USD&report_id=26421

Regional Analysis of the Collaboration Tool Market

North America and Europe remain at the forefront of the collaboration tool market, benefiting from advanced technological infrastructures, high digital literacy, and a culture of innovation. In these regions, established enterprises and tech giants continuously drive adoption through substantial investments in R&D and digital transformation initiatives. The mature ecosystems in these markets also foster rigorous data security standards and seamless integration with legacy systems, which further bolsters user confidence and sustained market growth.

In contrast, emerging markets in Asia-Pacific, Latin America, the Middle East, and Africa present unique opportunities alongside distinct challenges. The Asia-Pacific region, for example, is witnessing rapid digitalization driven by booming startup cultures and increasing remote work trends, while Latin America and the Middle East are investing heavily in digital infrastructures to support evolving business needs. Meanwhile, Africa faces hurdles related to connectivity and scalability, yet shows promising growth as regional investments and mobile technology adoption continue to improve access to collaborative solutions.

Recent Developments in the Collaboration Tool Market

The collaboration tool market is currently being shaped by several key developments, most notably the rapid integration of AI to enhance productivity and streamline workflows. AI-powered features are increasingly being used for tasks like automated meeting summaries, intelligent task prioritization, and real-time language translation. Furthermore, the continued prevalence of remote and hybrid work models is driving demand for robust and secure collaboration platforms that offer seamless communication, file sharing, and project management capabilities. Security remains a paramount concern, leading to advancements in data encryption and compliance measures. Finally, there is a clear trend towards consolidation and integration, with platforms striving to offer comprehensive suites that combine various collaboration functionalities into a unified user experience.

Top Trending Reports:

Face Voice Biometric Market- https://www.marketresearchfuture.com/reports/face-voice-biometric-market-26581

Graphics Card Market- https://www.marketresearchfuture.com/reports/collaboration-tool-market-26421

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Media Contact
Company Name: Market Research Future
Contact Person: Media Relations
Email: Send Email
Country: United States
Website: https://www.marketresearchfuture.com

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Collaboration Tool Market to Hit $84.10 Billion By 2034 | Empowering teams to collaborate, innovate, and succeed globally.

Gastric Cancer Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies

DelveInsight’s, “Gastric Cancer Pipeline Insight” report provides comprehensive insights about 200+ companies and 220+ pipeline drugs in Gastric Cancer pipeline landscape. It covers the Gastric Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Gastric Cancer therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

Explore our comprehensive Gastric Cancer Pipeline Report to stay informed about the latest advancements. Download copy now @ Gastric Cancer Pipeline Outlook

Key Takeaways from the Gastric Cancer Pipeline Report

  • In February 2025:- Bristol-Myers Squibb:- The purpose of this study is to determine the efficacy and safety of investigational drug relatlimab plus nivolumab in combination with chemotherapy in participants with unresectable, untreated, locally advanced or metastatic gastric or GEJ cancer.
  • In February 2025:- Jazz Pharmaceuticals:- This study is being done to find out if zanidatamab, when given with chemotherapy plus or minus tislelizumab, is safe and works better than trastuzumab given with chemotherapy. The patients in this study will have advanced human epidermal growth factor 2 (HER2)-positive stomach and esophageal cancers that are no longer treatable with surgery (unresectable) or chemoradiation, and/or have grown or spread to other parts of the body (metastatic).
  • In February 2025:- Bold Therapeutics, Inc.:- BOLD-100 is an intravenously administered sterile solution containing the ruthenium-based small molecule. BOLD-100 has been shown to preferentially decrease the expression of GRP78 in tumour cells and ER stressed cells when compared to normal cells. BOLD-100 will be combined with cytotoxic FOLFOX chemotherapy in this study, with a dose escalation cohort to ensure tolerability and safety, followed by a cohort expansion phase.
  • In February 2025:- AstraZeneca:- DESTINY-Gastric03 will investigate the safety, tolerability, pharmacokinetics, immunogenicity, and preliminary antitumor activity of trastuzumab deruxtecan (T-DXd) alone or in combination with chemotherapy and/or immunotherapy in HER2-expressing advanced/metastatic gastric/gastroesophageal junction (GEJ) and esophageal adenocarcinoma patients.
  • DelveInsight’s Gastric Cancer pipeline report depicts a robust space with 200+ active players working to develop 220+ pipeline therapies for Gastric Cancer treatment.
  • The leading Gastric Cancer Companies such as BeiGene, Linton Pharm Co. Ltd., RAPT Therapeutics, Leap Therapeutics, Idience, Bolt Biotherapeutics, Hubro Therapeutics, Immunocore, Ambrx, Hangzhou DAC Biotech, Beijing Immunoah Pharma Tech, Base Therapeutics, Nanjing KAEDI Biotech, HiberCell, Transcenta Holding, Suzhou Zelgen Biopharmaceuticals, Daiichi Sankyo, Ipsen, Alligator Bioscience, Bristol Myers Squibb, Jiangsu Hengrui Medicine, Shanghai Junshi Biosciences, ImmunoACT and others.
  • Promising Gastric Cancer Therapies such as Avelumab, BBI608, Camrelizumab, Catumaxomab, RAPA-201, SHR-1210, Amivantamab, Atezolizumab, Bevacizumab, Cabozantinib, Cinrebafusp alfa, Crizotinib, DKN-01, DP303c, Eflornithine, EP0057, Epacadostat, FLX475, Futibatinib, GEN-001, HLX07, HLX22, Infigratinib, KH903, Lenvatinib, Masitinib, MAX-40279, MRG002, MRG003, Niraparib, Savolitinib, Minnelide, SHR-1701, Margetuximab, Bemarituzumab, Evorpacept, Lenvatinib, CDK-004, TPX-0022, TCRx_T Cells, IN10018, IMU-131, SOT102, CT041, AB011, Zanidatamab, NC410, PT 886, PRS-343, Oraxol, CA-4948, Q702, ACE1702, SI-B001, TT-4, LUM015, LB 1908, CUE-102, TORL-2-307-MAB, OBI-833/OBI-821, ASP2138, NC410, SO-C101, HC-5404-FU, CPL304110, LNS8801, RGX-202-01, A166, GZ17-6.02, HMPL-453, CCT303-406, VMD-928, ITI 4000, PAb 001, and others.

Discover how the Gastric Cancer treatment paradigm is evolving. Access DelveInsight’s in-depth Gastric Cancer Pipeline Analysis for a closer look at promising breakthroughs @ Gastric Cancer Clinical Trials and Studies

Gastric Cancer Emerging Drugs

  • Tislelizumab: BeiGene

Tislelizumab (BGB-A317) is a humanized IgG4 anti-PD-1 monoclonal antibody specifically designed to minimize binding to FcγR on macrophages. In pre-clinical studies, binding to FcγR on macrophages has been shown to compromise the anti-tumor activity of PD-1 antibodies through activation of antibody-dependent macrophage-mediated killing of T effector cells. Tislelizumab is the first drug from BeiGene’s immuno-oncology biologics program and is being developed internationally as a monotherapy and in combination with other therapies for the treatment of a broad array of both solid tumor and hematologic cancers. The China National Medical Products Administration (NMPA) has approved tislelizumab in six indications. Including full approval for first-line treatment of patients with advanced squamous non-small cell lung cancer (NSCLC) in combination with chemotherapy, for first-line treatment of patients with advanced non-squamous NSCLC in combination with chemotherapy, and for second- or third-line treatment of patients with locally advanced or metastatic NSCLC who progressed on prior platinum-based chemotherapy. Tislelizumab is not approved for use outside of China. Currently the drug is registered for the treatment of gastric cancer.

  • Catumaxomab: Linton Pharm Co. Ltd.

Catumaxomab was approved by the European Medicines Agency in 2009 for the treatment of malignant ascites. It is a bispecific antibody that binds to EpCAM (the epithelial cell adhesion molecule) on the tumor cell–and CD3 on the T cell, recruits immune accessory cells through FcγR binding at the same time. Catumaxomab kills tumor cells by engaging T cell and accessory cell mediated cytotoxicity and has the potential to induce long-term vaccinal effects which has been verified in animal models. Currently, Catumaxomab is being evaluated in clinical trials for both advanced gastric cancer and non-muscle invasive bladder cancer. Currently the drug is in Phase III stage of development for the treatment of gastric cancer.

  • Tivumecirnon: RAPT Therapeutics

Tivumecirnon is a small molecule CCR4 antagonist designed to block the migration of regulatory T cells (Treg) specifically into tumors, but not healthy tissues. Treg represent a dominant pathway for downregulating the immune response, generally correlate with poor clinical outcomes and may limit the effectiveness of currently available therapies such as checkpoint inhibitors. Tivumecirnon may restore naturally occurring antitumor immunity alone and may synergize with a variety of both conventional and immune-based therapies, such as radiation, chemotherapy, checkpoint inhibitors, immune stimulators, cancer vaccines and adoptive T cell therapy. Currently the drug is in Phase II stage of development for the treatment of gastric cancer.

  • DKN-01: Leap Therapeutics

DKN-01 is a humanized monoclonal antibody that binds to and blocks the activity of the Dickkopf-1 (DKK1) protein, a modulator of Wnt/Beta-catenin signaling, a signaling pathway frequently implicated in tumorigenesis and suppressing the immune system. DKK1 has an important role in tumor cell signaling and in mediating an immuno-suppressive tumor microenvironment through enhancing the activity of myeloidderived suppressor cells and downregulating NK ligands on tumor cells. DKN-01 has received Orphan Drug Designation for the treatment of gastric and gastroesophageal junction cancer from the U.S. Food and Drug Administration. Currently the drug is in Phase II stage of development for the treatment of gastric cancer.

  • Venadaparib: Idience

Venadaparib (IDX-1197) is a potent PARP inhibitor that prevents the repair of DNA single-strand breaks (SSB) and promote the conversion of SSB to double-stranded breaks (DSB), which ultimately leads to synthetic lethality in cancer cells. IDX-1197 is under clinical development targeting multiple solid tumors as a monotherapy (including maintenance) and for combination with other anti-cancer agents. Currently the drug is in Phase I stage of development for the treatment of gastric cancer.

  • BDC-4182: Bolt Biotherapeutics

BDC-4182 is Bolt’s next-generation ISAC candidate targeting Claudin 18.2, a novel target in oncology, with programs in development for the treatment of gastric or gastroesophageal junction cancer and pancreatic cancer. Currently the drug is in Preclinical stage of development for the treatment of gastric cancer.

The Gastric Cancer pipeline report provides insights into

  • The report provides detailed insights about companies that are developing therapies for the treatment of Gastric Cancer with aggregate therapies developed by each company for the same.
  • It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Gastric Cancer Treatment.
  • Gastric Cancer Companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
  • Gastric Cancer Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
  • Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Gastric Cancer market.

Get a detailed analysis of the latest innovations in the Gastric Cancer pipeline. Explore DelveInsight’s expert-driven report today! @ Gastric Cancer Unmet Needs

Gastric Cancer Companies

BeiGene, Linton Pharm Co. Ltd., RAPT Therapeutics, Leap Therapeutics, Idience, Bolt Biotherapeutics, Hubro Therapeutics, Immunocore, Ambrx, Hangzhou DAC Biotech, Beijing Immunoah Pharma Tech, Base Therapeutics, Nanjing KAEDI Biotech, HiberCell, Transcenta Holding, Suzhou Zelgen Biopharmaceuticals, Daiichi Sankyo, Ipsen, Alligator Bioscience, Bristol Myers Squibb, Jiangsu Hengrui Medicine, Shanghai Junshi Biosciences, ImmunoACT and others.

Gastric Cancer pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as

  • Intravenous
  • Subcutaneous
  • Oral
  • Intramuscular

Gastric Cancer Products have been categorized under various Molecule types such as

  • Monoclonal antibody
  • Small molecule
  • Peptide

Download DelveInsight’s latest report to gain strategic insights into upcoming Gastric Cancer Therapies and key Gastric Cancer Developments @ Gastric Cancer Market Drivers and Barriers, and Future Perspectives

Scope of the Gastric Cancer Market Report

  • Coverage- Global
  • Gastric Cancer Companies- BeiGene, Linton Pharm Co. Ltd., RAPT Therapeutics, Leap Therapeutics, Idience, Bolt Biotherapeutics, Hubro Therapeutics, Immunocore, Ambrx, Hangzhou DAC Biotech, Beijing Immunoah Pharma Tech, Base Therapeutics, Nanjing KAEDI Biotech, HiberCell, Transcenta Holding, Suzhou Zelgen Biopharmaceuticals, Daiichi Sankyo, Ipsen, Alligator Bioscience, Bristol Myers Squibb, Jiangsu Hengrui Medicine, Shanghai Junshi Biosciences, ImmunoACT and others.
  • Gastric Cancer Therapies- Avelumab, BBI608, Camrelizumab, Catumaxomab, RAPA-201, SHR-1210, Amivantamab, Atezolizumab, Bevacizumab, Cabozantinib, Cinrebafusp alfa, Crizotinib, DKN-01, DP303c, Eflornithine, EP0057, Epacadostat, FLX475, Futibatinib, GEN-001, HLX07, HLX22, Infigratinib, KH903, Lenvatinib, Masitinib, MAX-40279, MRG002, MRG003, Niraparib, Savolitinib, Minnelide, SHR-1701, Margetuximab, Bemarituzumab, Evorpacept, Lenvatinib, CDK-004, TPX-0022, TCRx_T Cells, IN10018, IMU-131, SOT102, CT041, AB011, Zanidatamab, NC410, PT 886, PRS-343, Oraxol, CA-4948, Q702, ACE1702, SI-B001, TT-4, LUM015, LB 1908, CUE-102, TORL-2-307-MAB, OBI-833/OBI-821, ASP2138, NC410, SO-C101, HC-5404-FU, CPL304110, LNS8801, RGX-202-01, A166, GZ17-6.02, HMPL-453, CCT303-406, VMD-928, ITI 4000, PAb 001, and others.
  • Gastric Cancer Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
  • Gastric Cancer Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III

Which companies are leading the race in Gastric Cancer drug development? Find out in DelveInsight’s exclusive Gastric Cancer Pipeline Report—access it now! @ Gastric Cancer Emerging Drugs and Major Companies

Table of Content

  1. Introduction
  2. Executive Summary
  3. Gastric Cancer: Overview
  4. Pipeline Therapeutics
  5. Therapeutic Assessment
  6. Gastric Cancer– DelveInsight’s Analytical Perspective
  7. Late Stage Products (Phase III)
  8. Catumaxomab: Linton Pharm Co. Ltd.
  9. Drug profiles in the detailed report…..
  10. Mid Stage Products (Phase II)
  11. Tivumecirnon: RAPT Therapeutics
  12. Drug profiles in the detailed report…..
  13. Early Stage Products (Phase I)
  14. Venadaparib: Idience
  15. Drug profiles in the detailed report…..
  16. Preclinical and Discovery Stage Products
  17. BDC-4182: Bolt Biotherapeutics
  18. Drug profiles in the detailed report…..
  19. Inactive Products
  20. Gastric Cancer Key Companies
  21. Gastric Cancer Key Products
  22. Gastric Cancer- Unmet Needs
  23. Gastric Cancer- Market Drivers and Barriers
  24. Gastric Cancer- Future Perspectives and Conclusion
  25. Gastric Cancer Analyst Views
  26. Gastric Cancer Key Companies
  27. Appendix

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/report-store/medical-marijuana-market-insight

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Gastric Cancer Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies

The Boulder Group Arranges Sale of Freddy’s Frozen Custard & Steakburgers Property in Birmingham, AL

Zach Wright and Brandon Wright represent the seller and purchaser in the transaction.

The Boulder Group has completed the sale of a single tenant Freddy’s Frozen Custard & Steakburgers sale leaseback property located at 301 Doug Baker Blvd, Birmingham, AL for $1,833,333. Zach Wright and Brandon Wright represent the seller and purchaser in the transaction. The seller was a Freddy’s franchisee and the purchaser was a Midwest-based 1031 exchange investor.

The Freddy’s Frozen Custard & Steakburgers is positioned within a regional retail destination that includes a Publix, Dick’s Sporting Goods, Golf Galaxy, Hobby Lobby, AMC, and Panera. The property is located just off Highway 280 (56,000+ VPD) and in an extremely affluent area with average annual household income exceeding $173,000 within three miles.

The Freddy’s Frozen Custard & Steakburgers property features a new 20-year absolute triple net lease with zero landlord responsibilities and 2% annual rental increases. Freddy’s has approximately 550 locations across 36 states and is one of the fasted growing chains in the United States.

This was the 5th Freddy’s Frozen Custard & Steakburgers property sold by Zach Wright and Brandon Wright within the past thirteen months. The two previously sold the four lowest cap rates ever recorded nationally for Freddy’s properties according to CoStar.

“Freddy’s properties offer excellent real estate investment opportunities in addition to their made-to-order steakburgers and frozen custard. Most of their restaurants are well-located in dynamic retail trade areas and feature long-term triple net leases backed by strong franchisees. We continue to see substantial investor interest in Freddy’s properties,” stated Zach Wright, Vice President.

“Low rent and low price point quick service restaurant properties continue to be highly sought after amongst net lease investors,” added Brandon Wright, Associate.

 

About The Boulder Group

The Boulder Group is a boutique investment real estate service firm specializing in single tenant net lease properties. The firm provides a full range of brokerage, advisory, and financing services nationwide to a substantial and diversified client base, which includes high-net-worth individuals, developers, REITs, partnerships and institutional investment funds. Founded in 1997, the firm has arranged the acquisition and disposition of over $9 billion of single tenant net lease real estate transactions. From 2013-2024, the firm was ranked in the top 10 companies in the nation for single tenant retail transactions by both Real Capital Analytics and CoStar. The Boulder Group is headquartered in suburban Chicago and has an office in Denver.

Media Contact
Company Name: The Boulder Group
Contact Person: Zach Wright
Email: Send Email
Phone: 720-604-2220
Address:1805 S Bellaire Street, Suite 355 Suite 203
City: Denver
State: Colorado
Country: United States
Website: https://www.bouldergroup.com/NNN-Properties-For-Sale.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: The Boulder Group Arranges Sale of Freddy’s Frozen Custard & Steakburgers Property in Birmingham, AL

Event Logistics Market Expanding at a Healthy 6.20% CAGR, To Reach a Value of $ 143.56 Billion by 2034

“Event Logistics Market”
Rising corporate event spending growth in digital events increasing use of technology sustainability concerns expanding geographic reach

The event logistics market has undergone significant transformation in recent years, driven by the increasing complexity of global events, advancements in technology, and shifting consumer expectations. From large-scale international conferences and exhibitions to intimate corporate gatherings and virtual events, the demand for seamless logistics solutions has never been higher. As the industry continues to evolve, companies are leveraging innovative strategies to stay ahead of the curve, ensuring that events are executed flawlessly and sustainably.

In this dynamic environment, DHL Global Forwarding, a leading player in the logistics industry, has announced the expansion of its event logistics services to cater to the growing demand for specialized solutions. The company’s strategic move underscores its commitment to providing end-to-end support for event organizers, ensuring that every aspect of event planning and execution is handled with precision and efficiency.

Event Logistic Market Size was estimated at 78.36 (USD Billion) in 2024. The Event Logistic Industry is expected to grow from 83.25 (USD Billion) in 2025 to 143.56 (USD Billion) by 2034. The Event Logistic Market CAGR (growth rate) is expected to be around 6.2% during the forecast period (2025 – 2034).

The Growing Importance of Event Logistics

Event logistics encompasses the planning, coordination, and execution of all logistical elements required to host a successful event. This includes transportation of equipment, venue setup, catering, technology integration, and post-event breakdown. With the rise of hybrid and virtual events, the scope of event logistics has expanded to include digital infrastructure, such as live-streaming equipment and online platforms.

Key Trends Shaping the Event Logistics Market

  1. Hybrid and Virtual Events: A New Normal The pandemic accelerated the adoption of hybrid and virtual events, and this trend is here to stay. Event logistics providers are now tasked with managing both physical and digital components, ensuring seamless integration between the two. Companies are investing in advanced technologies such as live-streaming platforms, virtual reality (VR), and augmented reality (AR) to enhance the attendee experience.
  2. Sustainability Takes Center Stage As environmental concerns grow, event organizers are prioritizing sustainability in their logistics planning. This includes reducing waste, using eco-friendly materials, and optimizing transportation routes to minimize carbon emissions. Leading logistics providers are responding by offering green solutions, such as electric vehicles, reusable event structures, and digital alternatives to printed materials.
  3. Technology-Driven Solutions The integration of technology into event logistics has revolutionized the industry. From AI-powered inventory management systems to real-time tracking tools, technology is enabling greater efficiency and transparency. Companies are also leveraging data analytics to predict demand, optimize resource allocation, and improve overall event outcomes.
  4. Customization and Personalization Today’s event attendees expect personalized experiences tailored to their preferences. Event logistics providers are responding by offering customizable solutions, from modular venue designs to bespoke catering options. This trend is particularly evident in corporate events, where branding and attendee engagement are paramount.
  5. Globalization and Cross-Border Events As businesses expand their reach, the demand for cross-border event logistics has grown. Managing international events requires expertise in customs regulations, international shipping, and local compliance. Leading logistics providers are expanding their global networks to offer end-to-end solutions for clients hosting events in multiple countries.

 

Download Report Sample Copy with TOC: https://www.marketresearchfuture.com/sample_request/25125

 

Key Companies in the Event Logistic Market Include:

 

  • DHL Supply Chain
  • Dachser
  • Expeditors International of Washington
  • Nippon Express
  • Hellman Worldwide Logistics
  • Agility Logistics
  • DB Schenker
  • FedEx Trade Networks

 

Event Logistic Market Segment Insights:

The Event Logistic Market segmentation by Service Type Transportation, Warehousing and Storage, Event Staffing, Production Services, Marketing and Promotion

The Event Logistic Market segmentation by event size includes Small (up to 500 attendees), Medium (500 to 2,000 attendees), Large (2,000 to 10,000 attendees), and Mega (over 10,000 attendees).

The Event Logistic Market can be segmented based on Event Type, which includes Corporate Events, Social Events, Sporting Events, Cultural Events, and Educational Events.

Buy Now: https://www.marketresearchfuture.com/checkout?currency=one_user-USD&report_id=25125

Challenges in the Event Logistics Market

Despite the promising growth prospects, the event logistics market faces several challenges:

  • Supply Chain Disruptions: The global supply chain crisis has impacted the availability of event materials and equipment, leading to delays and increased costs.
  • Labor Shortages: The events industry is grappling with a shortage of skilled workers, particularly in areas such as technical support and onsite coordination.
  • Rising Costs: Inflation and increased demand have driven up the cost of logistics services, putting pressure on event budgets.
  • Security Concerns: Ensuring the safety and security of attendees, especially at large-scale events, remains a top priority for organizers and logistics providers.

 

Browse the Complete Report: https://www.marketresearchfuture.com/reports/event-logistic-market-25125

 

Company News: How Leading Players Are Innovating

Several companies in the event logistics space are making headlines with their innovative approaches to addressing market challenges and capitalizing on emerging opportunities. Here are a few notable examples:

  1. DHL Global Forwarding: Pioneering Sustainable Event Logistics DHL Global Forwarding, a division of Deutsche Post DHL Group, has launched a new sustainability initiative aimed at reducing the environmental impact of event logistics. The company is offering carbon-neutral shipping options, eco-friendly packaging materials, and end-to-end sustainability consulting for event organizers. DHL’s efforts align with its broader goal of achieving net-zero emissions by 2050.
  2. Agility: Expanding Global Reach Agility, a leading logistics provider, has announced the expansion of its event logistics division to cater to the growing demand for cross-border events. The company has established new offices in key markets across Asia, Europe, and North America, enabling it to offer localized support and expertise. Agility’s investment in technology, including its proprietary event management platform, has also enhanced its ability to deliver seamless logistics solutions.
  3. FedEx Logistics: Leveraging Technology for Efficiency FedEx Logistics has introduced a suite of technology-driven solutions designed to streamline event logistics operations. These include real-time tracking tools, predictive analytics, and automated inventory management systems. The company’s focus on innovation has positioned it as a preferred partner for large-scale events, including international trade shows and corporate conferences.
  4. UPS Event Logistics: Enhancing Customer Experience UPS Event Logistics has rolled out a new customer portal that provides event organizers with greater visibility and control over their logistics operations. The portal features real-time updates, customizable reporting, and 24/7 support. UPS has also invested in training programs to address the labor shortage and ensure a high standard of service delivery.
  5. Schenker: Focusing on Hybrid Events Schenker, a subsidiary of DB Schenker, has developed a specialized division dedicated to hybrid events. The company offers integrated solutions that combine physical and digital logistics, including live-streaming equipment, virtual event platforms, and onsite technical support. Schenker’s expertise in hybrid events has made it a go-to partner for organizations transitioning to this format.

 

Related Report

Rail Logistics Market

Ampoule Sticker Labelling Machine Market

Animal Transportation Market

Apparel Logistics Market

Art Logistic Market

Automated Parcel Delivery Terminal Market

 

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research Consulting Services. The MRFR team have a supreme objective to provide the optimum quality market research and intelligence services for our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments enable our clients to see more, know more, and do more, which help to answer all their most important questions.

 

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,

5Th Floor, New York,

New York 10013

United States of America +1 628 258 0071

Email: sales@marketresearchfuture.com

Media Contact
Company Name: Market Research Future
Contact Person: Media Relations
Email: Send Email
Country: United States
Website: https://www.marketresearchfuture.com

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Event Logistics Market Expanding at a Healthy 6.20% CAGR, To Reach a Value of $ 143.56 Billion by 2034

Voyage Management Software Market Valued at USD 2.13 Billion in 2024, Forecasted for Robust Growth

“With a market size of USD 2.13 billion in 2024, the Voyage Management Software Market is expanding rapidly, fueled by technological advancements in shipping logistics, route optimization, and real-time fleet tracking solutions.”
The Voyage Management Software Market is anticipated to expand from USD 2.29 billion in 2025 to USD 4.33 billion by 2034, reflecting a compound annual growth rate (CAGR) of 7.32% throughout the forecast period (2025–2034). Furthermore, the market size for Voyage Management Software was estimated at USD 2.13 billion in 2024.

The voyage management software market is experiencing significant growth, driven by the increasing demand for efficient maritime operations, real-time data analytics, and enhanced fleet management. Voyage management software provides comprehensive solutions for planning, tracking, and optimizing vessel routes, ensuring improved fuel efficiency and regulatory compliance. The maritime industry is undergoing rapid digital transformation, with stakeholders seeking solutions that reduce operational costs and enhance sustainability. The integration of artificial intelligence, machine learning, and big data analytics into voyage management software has revolutionized the sector, allowing shipping companies to make data-driven decisions and improve overall performance. The market is also being influenced by stringent environmental regulations that require shipping companies to adopt more efficient navigation systems to reduce carbon emissions. As globalization drives international trade, the demand for effective voyage management software continues to rise, with major shipping lines, cargo carriers, and logistics providers investing in advanced digital solutions to streamline their operations.

Get An Exclusive Sample of the Research Report at: https://www.marketresearchfuture.com/sample_request/24842

Market SegmentationThe voyage management software market can be segmented based on component, deployment mode, application, and end-user. By component, the market is divided into software solutions and services, with software solutions holding a significant share due to increasing automation in maritime operations. Deployment mode is categorized into cloud-based and on-premises solutions, with cloud-based platforms witnessing higher adoption due to their scalability, accessibility, and cost-effectiveness. In terms of application, the market includes fleet management, route optimization, fuel management, regulatory compliance, and performance monitoring. Fleet management and route optimization are key applications as shipping companies seek to enhance operational efficiency and reduce costs. The end-user segment comprises shipping companies, logistics providers, port authorities, and government agencies, with shipping companies accounting for the largest share due to their direct involvement in vessel management and voyage planning.

Market Key PlayersThe voyage management software market features several prominent players that offer advanced solutions for maritime operations. Companies such as:

  • Cargotec
  • Chevron
  • Wartsila
  • ExxonMobil
  • Marine Software Solutions
  • MacGregor
  • Wilhelmsen
  • GEA
  • Shell
  • Transas
  • Yara Marine Technologies
  • BP
  • Alfa Laval
  • OrbitMI Technologies
  • Veson Nautical
  • SeaRates

Buy this Premium Research Report | Immediate Delivery Available at – https://www.marketresearchfuture.com/checkout?currency=one_user-USD&report_id=24842

Market OpportunitiesThe growing emphasis on sustainable shipping practices presents a significant opportunity for the voyage management software market. As the shipping industry faces increasing pressure to reduce carbon emissions, voyage optimization software can play a crucial role in achieving sustainability goals. The adoption of AI-powered predictive analytics is another major opportunity, enabling real-time monitoring of vessel performance, fuel consumption, and maintenance requirements. The integration of blockchain technology in voyage management software is also gaining traction, enhancing transparency, security, and data integrity in maritime operations. Additionally, the expansion of global trade and the rise of e-commerce have increased the demand for efficient logistics and supply chain solutions, driving the adoption of advanced voyage management software. Emerging economies in Asia-Pacific and Latin America present untapped growth opportunities, with governments and private enterprises investing in maritime infrastructure and digital transformation.

Regional AnalysisThe voyage management software market exhibits regional variations, with North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa being key geographical segments. North America leads the market due to the presence of major shipping companies, advanced maritime infrastructure, and high adoption of digital solutions. Europe follows closely, driven by stringent environmental regulations and a strong emphasis on sustainable shipping practices. The Asia-Pacific region is expected to witness the highest growth rate, attributed to the rapid expansion of international trade, increasing maritime activities, and government initiatives to modernize ports and shipping operations. China, Japan, and South Korea are major contributors to the market in this region, with strong investments in smart shipping technologies. Latin America and the Middle East & Africa are also emerging markets, with growing maritime trade and infrastructure development fostering demand for advanced voyage management solutions.

Recent DevelopmentsThe voyage management software market is witnessing continuous advancements and strategic collaborations. Companies are integrating AI, machine learning, and big data analytics to enhance predictive maintenance and optimize voyage planning. In recent years, Wärtsilä launched its Smart Marine Ecosystem, focusing on digital transformation and automation in the maritime sector. Kongsberg Gruppen introduced advanced navigation systems equipped with AI-driven analytics for real-time decision-making. ABB Ltd has expanded its digital maritime solutions with new fuel efficiency modules, helping shipping companies comply with environmental regulations. SAP SE has enhanced its logistics and supply chain integration capabilities, enabling seamless data sharing across stakeholders. The adoption of blockchain technology is also gaining traction, with several industry players exploring its potential to improve transparency and reduce fraud in maritime operations. As digitalization accelerates, the voyage management software market is set to experience substantial growth, driven by innovation, regulatory compliance, and the increasing demand for efficient maritime operations.

Top Trending Reports:

Augmented Reality Glas Market: https://www.marketresearchfuture.com/reports/augmented-reality-glas-market-26402

Cloud Logistic Market: https://www.marketresearchfuture.com/reports/cloud-logistic-market-26413

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Media Contact
Company Name: Market Research Future
Contact Person: Media Relations
Email: Send Email
Country: United States
Website: https://www.marketresearchfuture.com

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Voyage Management Software Market Valued at USD 2.13 Billion in 2024, Forecasted for Robust Growth

Dyspnea Market Expected to rise, 2032 | United Therapeutics Corporation, Actelion Pharmaceuticals Ltd., Relief Therapeutics, AstraZeneca, GlaxoSmithKline, Novartis AG, Boehringer Ingelheim

“Dyspnea Market Expected to rise 2032, DelveInsight”
The Dyspnea market growth is driven by factors like increase in the prevalence of Dyspnea, investments in research and development, entry of emerging therapies during the study period 2020-2032.

The Dyspnea market report also offers comprehensive insights into the Dyspnea market size, share, Dyspnea epidemiology, emerging therapies, market drivers and barriers, ongoing clinical trials, key collaboration in the space, market uptake by key therapies and companies actively pushing Dyspnea market size growth forward.

Some of the key highlights from the Dyspnea Market Insights Report:

  • Several key pharmaceutical companies, including United Therapeutics Corporation, Actelion Pharmaceuticals Ltd., Relief Therapeutics, AstraZeneca, GlaxoSmithKline, Novartis AG, Boehringer Ingelheim, and others, are developing novel products to improve the Dyspnea treatment outlook.

  • In October 2024, the FDA approved Dupixent as an add-on maintenance treatment for adults with inadequately controlled chronic obstructive pulmonary disease (COPD) characterized by eosinophilic inflammation. This marks the first biologic therapy approved for COPD in the U.S., aiming to reduce exacerbations and improve lung function. ​

  • Approved by the FDA in June 2024, Ohtuvayre is an inhaled maintenance therapy for adults with COPD. As a first-in-class dual inhibitor of phosphodiesterase 3 and 4, it offers both bronchodilator and anti-inflammatory effects, enhancing lung function and reducing symptom exacerbations. ​

  • In March 2024, the FDA approved sotatercept for treating PAH in adults. This novel therapy improves exercise capacity and reduces the risk of clinical worsening events by targeting activin signaling pathways, offering a new approach to managing PAH-related dyspnea. ​

  • In August 2024, the FDA granted Breakthrough Therapy Designation to Tezspire as an add-on maintenance treatment for patients with moderate to very severe COPD characterized by an eosinophilic phenotype. This designation facilitates the development and review of therapies that may offer substantial improvements over existing treatments. ​

  • As per DelveInsight analysis, the Dyspnea market is anticipated to witness growth at a considerable CAGR

Strategise your business goals by understanding market dynamics @ Dyspnea Market Landscape

Dyspnea Overview

Dyspnea is the medical term for shortness of breath or difficulty breathing. It can feel like a tightness in the chest, a sensation of suffocation, or an increased effort to breathe.

Do you know the treatment paradigms for different countries? Download our Dyspnea Market Sample Report

Dyspnea Epidemiology Insights

  • Dyspnea is notably prevalent among oncology patients, particularly those with advanced stages of cancer.

Dyspnea Epidemiology Segmentation

DelveInsight’s Dyspnea market report is prepared on the basis of epidemiology model. It offers comprehensive insights to the Dyspnea historical patient pools and forecasted Dyspnea patients. The report provides in-depth data of various subtypes and for the same epidemiology is segmented further. The Dyspnea Market report proffers epidemiological analysis for the study period 2020-32 in the 7MM segmented into:

  • Dyspnea Prevalence

  • Age-Specific Dyspnea Prevalence

  • Gender-Specific Dyspnea Prevalence

  • Diagnosed and Treatable Cases of Dyspnea

Visit for more @ Dyspnea Epidemiological Insights

Dyspnea Market Outlook

​The global dyspnea treatment market is experiencing significant growth, driven by the increasing prevalence of respiratory disorders such as chronic obstructive pulmonary disease (COPD), asthma, and pneumonia.

Key Factors Driving Dyspnea Market Growth:

  • Rising Respiratory Disorders: The increasing incidence of conditions like COPD and asthma contributes significantly to the demand for dyspnea treatments. ​

  • Air Pollution: Elevated pollution levels exacerbate respiratory issues, leading to a higher prevalence of dyspnea. ​

  • Aging Population: An older demographic is more susceptible to respiratory ailments, thereby increasing the need for effective dyspnea management.

The dyspnea treatment market is poised for substantial growth in the coming years, driven by factors such as the rising prevalence of respiratory disorders, environmental challenges, and demographic shifts. Ongoing advancements in treatment modalities and increased healthcare investments are expected to further propel market expansion.

Dyspnea Key Companies

  • United Therapeutics Corporation, Actelion Pharmaceuticals Ltd., Relief Therapeutics, AstraZeneca, GlaxoSmithKline, Novartis AG, Boehringer Ingelheim, and others

For more information, visit Dyspnea Market Analysis, Patient Pool, and Emerging Therapies

Scope of the Dyspnea Market Report:

  • 11 Years Forecast

  • 7MM Coverage

  • Descriptive overview of Dyspnea, causes, signs and symptoms, diagnosis, treatment

  • Comprehensive insight into Dyspnea epidemiology in the 7MM

  • Dyspnea marketed and emerging therapies

  • Dyspnea companies

  • Dyspnea market drivers and barriers

Table of Contents:

1 Dyspnea Market Key Comprehensive Insights

2 Dyspnea Market Report Introduction

3 Competitive Intelligence Analysis for Dyspnea

4 Dyspnea Market Analysis Overview at a Glance

5 Executive Summary of Dyspnea

6 Dyspnea Epidemiology and Market Methodology

7 Dyspnea Epidemiology and Patient Population

8 Dyspnea Patient Journey

9 Dyspnea Treatment Algorithm, Dyspnea Current Treatment, and Medical Practices

10 Key Endpoints in Dyspnea Clinical Trials

11 Dyspnea Marketed Therapies

12 Dyspnea Emerging Therapies

13 Dyspnea: 7 Major Market Analysis

14 Attribute analysis

15 Access and Reimbursement Overview of Dyspnea

16 Dyspnea Market Key Opinion Leaders Reviews

18 Dyspnea Market Drivers

19 Dyspnea Market Barriers

20 SWOT Analysis

21 Disclaimer

22 DelveInsight Capabilities

23 About DelveInsight

Related Reports:

Dyspnea Epidemiology 2032

DelveInsight’s “Dyspnea – Epidemiology Forecast to 2032” report delivers an in-depth understanding of the disease, historical and forecasted Dyspnea epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Dyspnea Pipeline 2024

“Dyspnea Pipeline Insights, 2024” report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Dyspnea market. A detailed picture of the Dyspnea pipeline landscape is provided, which includes the disease overview and Dyspnea treatment guidelines.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Dyspnea Market Expected to rise, 2032 | United Therapeutics Corporation, Actelion Pharmaceuticals Ltd., Relief Therapeutics, AstraZeneca, GlaxoSmithKline, Novartis AG, Boehringer Ingelheim

New Jersey Small Businesses Enhance Payroll Processing Process to Meet Evolving Compliance Requirements

“payroll processing process in New Jersey”
Small businesses in New Jersey are optimizing their payroll processing process to meet evolving tax laws and compliance requirements. With growing complexities in payroll management, companies are turning to streamlined solutions to avoid costly errors, ensure timely filings, and enhance operational efficiency. Expert-led payroll services help businesses simplify payroll operations while staying compliant.

Miami, Florida, March 03, 2025 – New Jersey’s small businesses and startups are enhancing their payroll processing process to stay ahead of evolving tax laws and compliance requirements. As businesses face increasing pressure to meet regulatory mandates and ensure accurate salary processing, many owners are turning to streamlined solutions to avoid costly errors and penalties. With the growing complexity of payroll management, businesses are adopting smarter payroll processing process in New Jersey to reduce operational disruptions and ensure seamless tax calculations, timely filings, and employee classifications. This proactive approach helps businesses navigate challenges while supporting growth and financial stability.

Payroll Processing Process in New Jersey involves more than salary distribution. Employers must handle tax withholdings, comply with wage laws, manage benefits deductions, and meet strict federal and state tax deadlines. For startups lacking dedicated payroll personnel, these responsibilities can become overwhelming, increasing the risk of costly errors and missed deadlines. Compliance with New Jersey’s labor laws—including minimum wage updates, paid leave policies, and overtime regulations—requires expert knowledge that many small businesses may not have.

“New Jersey businesses need a payroll system that minimizes errors, ensures compliance, and streamline operations,” said Ajay Mehta, CEO of IBN Technologies. “By outsourcing payroll, small businesses can focus on growth while eliminating the stress of tax filings, wage calculations, and compliance monitoring.”

Managing the payroll processing process in New Jersey demands careful attention to employee classifications, tax deductions, and year-end reporting. Errors in Social Security, Medicare, or unemployment insurance contributions can lead to legal consequences. Additionally, businesses that engage independent contractors must ensure accurate classification to avoid regulatory scrutiny. For many startups, these complex payroll requirements make outsourcing a practical and cost-effective solution.

IBN Technologies simplifies payroll management with cloud-based transformation that reduces manual errors while ensuring full compliance with state and federal laws. The company’s payroll services include direct deposit processing, advanced tax filings, preparation of employee tax documents, benefits administration, and secure payroll data management. By seamlessly integrating with existing accounting systems, IBN Technologies enables businesses to optimize payroll operations without disruptions.

Book Your Free Consultation! Get personalized financial solutions—Book Now-

https://www.ibntech.com/free-consultation/?pr=ABnewswire

“Payroll compliance is critical for business stability,” added Mehta. “By leveraging automation and expert-led payroll services, small businesses can reduce financial risks and enhance operational efficiency.”

Security is another key factor in the payroll processing process in New Jersey. Handling sensitive employee data requires stringent security measures to prevent fraud and unauthorized access. IBN Technologies employs advanced encryption and cloud-based security protocols to ensure that payroll data always remains protected.

Custom Plans for Every Business! Find a bookkeeping package that fits your budget now- https://www.ibntech.com/pricing/?pr=ABnewswire

For small businesses and startups an efficient payroll processing process in New Jersey is essential for financial growth and operational stability. Partnering with IBN Technologies allows business owners to streamline payroll operations, improve compliance, and gain peace of mind knowing their payroll is managed by industry professionals. With a focus on accuracy, security, and regulatory compliance, IBN Technologies empowers businesses to navigate payroll complexities effortlessly, allowing them to concentrate on expansion and long-term success.

Related services:                     

Tax Preparation and Support            

https://ibntech.com/us-uk-tax-preparation-services/?pr=ABnewswire

About IBN Technologies                            

IBN Technologies LLC, an outsourcing specialist with 25 years of experience, serves clients across the United States, United Kingdom, Middle East, and India. Renowned for its expertise in RPA, Intelligent process automation includes AP Automation services like P2P, Q2C, and Record-to-Report. IBN Technologies provides solutions compliant with ISO 9001:2015, 27001:2022, CMMI-5, and GDPR standards. The company has established itself as a leading provider of IT, KPO, and BPO outsourcing services in finance and accounting, including CPAs, hedge funds, alternative investments, banking, travel, human resources, and retail industries. It offers customized solutions that drive efficiency and growth.

Media Contact
Company Name: IBN Technologies LLC
Contact Person: Pradip
Email: Send Email
Phone: +1844-644-8440
Address:66, West Flagler Street Suite 900 Miami, FL, USA 33130
City: Miami
State: Florida
Country: United States
Website: https://www.ibntech.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: New Jersey Small Businesses Enhance Payroll Processing Process to Meet Evolving Compliance Requirements

Aquafeed Market Expansion: Trends, Growth Drivers, Opportunities, Top Companies, and Future Outlook

“MarketsandMarkets™”
Aquafeed Market Size, Share, and Growth Trends Report by Ingredient (Soybean, Corn, Fishmeal, Fish Oil, Additives), Species (Fish, Crustaceans, Mollusks), Function (Nutrition, Growth Promoters, Immunity, Texture & Palatability), Lifecycle, Form and Region – Global Industry Forecast to 2029

The global aquafeed market is on a trajectory of significant expansion, with an estimated value projected to reach USD 84.19 billion by 2029 from the 2024 valuation of USD 58.92 billion, displaying a promising Compound Annual Growth Rate (CAGR) of 7.4%. Demand for seafood and innovation in aquaculture technologies are driving the growth of the aquafeed market. According to FAO, global aquaculture production in 2022 reached a record level of 130.9 million tonnes, which represents 51% of global fish production. This surge in aquaculture has resulted in demand for high-quality aquafeed to ensure optimum growth and health in farmed species of aquatic origin.

Aquafeed Market

According to NMFS, US aquaculture production reached more than 660 million pounds of seafood in 2022 alone; this level of production was backed by the aquafeed market. According to the USDA, there has been a steady increase in aquafeed production, driven by rising domestic aquaculture practices and specialized feed formulations.

Aquafeed Market Drivers: Increase in usage of functional aquafeed additives

The key reason behind the growing use of functional aquafeed additives is the increasing prevalence of aquatic diseases, which pose serious threats to fish and shrimp farming industries. Rising water temperatures further exacerbate the issue by creating favorable conditions for the rapid spread of infectious fish diseases. A study by NCBI (National Center for Biotechnology Information) published in October 2024, analyzing 104 papers from 2003 to 2022 found that 54% of the research focused on parasites, especially proliferative kidney disease, with 22% examining bacterial infections in fishes. Most studies emphasized freshwater species and farmed fish, showing that increased temperatures, along with factors like pH and salinity changes, pose major threats to fish health and global aquaculture.

This surge in disease prevalence is a key driver behind the growing use of functional aquafeed additives. Probiotics, prebiotics, and immune-boosting compounds are being increasingly integrated into aquafeeds to combat these health risks. Functional additives help improve gut health, enhance immunity, and reduce disease outbreaks, offering a sustainable solution to the challenges posed by climate change and its effects on fish. Therefore, addressing aquatic pathogens through improved management and the use of functional additives has become more essential.

Aquafeed Market Opportunities: Growth in support from governments

The growing support from governments worldwide presents significant opportunities for the aquafeed market, especially as global demand for seafood is projected to increase by 70% over the next 30 years (source: USDA). With capture fisheries’ harvests either stable or declining, the need for a rapid expansion in aquaculture has become increasingly evident. Governments are recognizing this and have ramped up efforts to ensure the sustainable growth of the aquaculture industry, offering a range of funding and support initiatives that create a conducive environment for innovation and growth in aquafeed production.

In the United States, the National Institute of Food and Agriculture (NIFA) plays a crucial role in driving research, technology development, and Extension programs related to aquaculture. For example, NIFA’s efforts in supporting innovations to enhance feed formulations, disease prevention, and sustainable aquaculture practices are directly contributing to better-aquafeed products. By investing in aquaculture research that improves feed efficiency and sustainability, government initiatives create significant opportunities for the development of functional additives, alternative feed sources, and environmentally friendly ingredients in aquafeeds. These advancements are crucial for responding to the challenges of increased global seafood demand and reduced availability of traditional feed ingredients.

Dry form accounted for higher market share among form segments in 2023.

In the aquafeed market, the dry form includes pellets, crumbles, and powders. Dry feeds are mainly predominant due to the facility and convenience they provide over the other forms. Dry aquafeeds are easier to store, handle, and move compared to wet and liquid feeds that need more delicate management to avoid spoilage or contamination. This particularly fits large-scale aquaculture operations where logistic efficiency is very important.

Dry feeds in pellet form are favored by many aqua culturists as they offer a stable and precisely formulated nutritional profile. These feeds are designed to meet the specific dietary needs of various aquatic species, ensuring they receive balanced nutrition for optimal growth. Companies like ADM(US) and Cargill Incorporated (US) produce pelletized feeds for species such as salmon and shrimp, carefully blending proteins, fats, vitamins, and minerals in exact proportions.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1151

Grower feed in lifecycle segment to be dominant market during forecast period.

Grower aquafeed meets the demand of aquatic species, switching to a more developed growth stage, normally containing 30–40% protein, which supports the continuity of development but synchronizes growth at reduced rates. It is cost-effective as it provides a balanced nutritional formulation tailored for optimal fish growth. Its pelletized form improves feed efficiency, reducing waste and enhancing nutrient absorption. This results in better growth and lower feed costs, making it economical for large-scale aquaculture operations. Grower feed, mostly in pelletized form, improves feed utilization and reduces waste due to the advanced feeding skills of the fish. Better feed conversion and lower waste combine with increased efficiency to help trigger growth. Technological advancements have led to grower feeds being refined with additives such as probiotics and prebiotics, enhancing performance and ensuring animal health. This has further cemented the importance of this stage in the industry. The dominance of grower feeds in the aquafeed lifecycle stage stems from their increasing ability to meet the nutritional requirements of fish, thus contributing to the sustainability and efficiency of the aquaculture industry.

Asia Pacific is the fastest growing region in the aquafeed market.

According to the FAO, in 2022, Asia produced 119.7 million tons of aquaculture, representing 91.4% of the global production. China led with 40%, followed by Indonesia with 10% and India with 7%. This significant output underscores Asia’s dominance in global aquaculture. This intensive production is directly related to the high demand for seafood, which has resulted from a large, growing population and rising per-capita incomes. According to the National Bureau of Statistics of China in 2023, the country is the largest producer and consumer of seafood globally; it consumes approximately 63.4 million metric tons annually. Producers are compelled to expand and enhance their offerings to meet the nutritional needs of aquaculture farms. Government policies in the region further back this growth. The 14th Five-Year Plan of China focuses on both sustainable aquaculture and technological innovation, thereby improving production efficiency. Similarly, the Indian National Fisheries Policy is targeted at expansion in aquaculture and infrastructure investments, thus stimulating growth in the market.

Top 10 Companies in the Aquafeed Market

Cargill, Incorporated (US)

dsm-firmenich (Switzerland)

Nutreco (Netherlands)

Alltech (US)

Purina Animal Nutrition LLC (US)

Adisseo (France)

Aller Aqua Group (Denmark)

BioMar Group (Denmark)

Recent Developments of Aquafeed industry

In December 2024, Aller Aqua Group partnered with AquaRech to improve access to high-quality fish feeds for fish farmers across Kenya. This collaboration combines Aller Aqua’s expertise in premium feed production with AquaRech’s extensive Last Mile Distribution System, ensuring consistent supply and accessibility in key regions. The partnership is set to enhance fish health and growth, significantly reducing production cycles from 14 to 8 months, while supporting sustainable aquaculture practices. This strengthens Aller Aqua’s position as one of the leaders in the African aquaculture industry, driving growth and supporting local farming communities.

In June 2024, Nutreco launched its innovative “Garden of the Future,” marking a significant advancement in phytotechnology. This groundbreaking initiative focuses on developing cutting-edge phytotechnology solutions designed to enhance the performance, health, and welfare of aquatic species, as well as farm and companion animals. The “Garden of the Future” represents a forward-thinking approach, leveraging advanced plant-based technologies to improve animal nutrition and overall well-being.

In January 2024, the joint venture between ADM and Vitafort opened a new state-of-the-art feed mill in Hungary that is poised to achieve full production capacity. This reflects ADM’s steadfast commitment to ushering in a new era of modernization in the region’s production infrastructure.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=1151

About MarketsandMarkets™

MarketsandMarketsTM has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

 

Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/aquafeeds-market-1151.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Aquafeed Market Expansion: Trends, Growth Drivers, Opportunities, Top Companies, and Future Outlook

AI in Asset Management Market Poised to Reach USD 920.51 Billion, Expanding at a 26.92% CAGR by 2034

“” AI in Asset Management Market: A financial analyst using AI-driven dashboards with predictive analytics, stock market trends, and automated investment insights “”
AI in asset management market is revolutionizing financial services by leveraging machine learning and predictive analytics to optimize investment strategies and risk management.

Market Overview:

According to a new report published by Market Research Future (MRFR), AI in Asset Management Market is expected to expand from USD 107.69 billion in 2025 to USD 920.51 billion by 2034, reflecting a CAGR of 26.92% over the forecast period (2025–2034). Furthermore, the market was valued at USD 84.85 billion in 2024.

The integration of Artificial Intelligence (AI) into the asset management sector has revolutionized traditional investment strategies, offering enhanced data analysis, improved decision-making, and operational efficiency. This transformation is driven by the need to process vast amounts of data swiftly and accurately, enabling asset managers to respond to market dynamics with unprecedented agility.

AI technologies facilitate portfolio optimization, risk assessment, and predictive analytics, thereby enhancing the overall efficiency and effectiveness of asset management operations.

Download Sample Report (Get Full Insights in PDF – 128 Pages) at –https://www.marketresearchfuture.com/sample_request/26543

Key Companies in the AI in Asset Management Market Include:

  • State Street Corporation
  • BlackRock
  • Schroders
  • Franklin Templeton Investments
  • P. Morgan Asset Management
  • Allianz Global Investors
  • Rowe Price
  • Invesco
  • Amundi Asset Management
  • Vanguard
  • Fidelity Investments
  • UBS Asset Management
  • Morgan Stanley Investment Management
  • Goldman Sachs Asset Management
  • Northern Trust Asset Management

 

Several prominent organizations are leading the integration of AI into asset management. Companies such as BlackRock, Vanguard, and State Street have incorporated AI-driven tools to optimize portfolio management and enhance client services. Technology giants like IBM and Microsoft provide AI solutions tailored for financial services, enabling asset managers to leverage machine learning and natural language processing for data analysis and decision support. Additionally, fintech firms like Numerai and Kensho are introducing innovative AI applications, offering predictive modeling and analytics that challenge traditional asset management paradigms.

Market Segmentation:

The AI in asset management market can be segmented based on technology, deployment mode, application, and industry vertical.

By Technology: This includes machine learning, natural language processing (NLP), predictive analytics, and other emerging AI technologies.

By Deployment Mode: Solutions are offered either on-premises or via cloud-based platforms, with cloud adoption increasing due to its scalability and cost-effectiveness.

By Application: Key applications encompass portfolio optimization, risk and compliance management, process automation, conversational platforms, and data analysis.

By Industry Vertical: While the primary focus is on banking, financial services, and insurance (BFSI), other sectors such as healthcare, retail, e-commerce, media and entertainment, energy and utilities, and automotive are also exploring AI-driven asset management solutions.

Market Dynamics:

The rapid adoption of AI in asset management is influenced by several factors:

Data-Driven Decision Making: AI enables the analysis of large datasets to identify patterns and trends, facilitating informed investment decisions.

Operational Efficiency: Automation of routine tasks through AI reduces operational costs and minimizes human errors.

Regulatory Compliance: AI assists in monitoring compliance with evolving regulations, ensuring that asset management practices adhere to legal standards.

Client Personalization: AI-driven insights allow for the customization of investment strategies to meet individual client preferences and risk profiles.

However, challenges persist, including concerns about data privacy, the need for significant initial investments, and the requirement for skilled personnel to manage AI systems. Moreover, ensuring the transparency and interpretability of AI models remains a critical issue to build trust among stakeholders.

Recent Developments:

The AI in asset management landscape is continually evolving, marked by notable developments:

Mergers and Acquisitions: Asset managers are engaging in strategic partnerships and acquisitions to enhance their AI capabilities. For instance, Amundi’s acquisition of wealth software firm Aixigo for €149 million exemplifies efforts to integrate advanced AI solutions into traditional asset management frameworks.

AI-Powered Financial Advisory Services: Platforms like Robinhood have announced plans to introduce AI-driven financial advice, aiming to provide cost-efficient support for portfolio management, tax planning, and retirement strategies. This initiative reflects a broader trend of democratizing access to sophisticated investment tools through AI.

AI-Focused Investment Funds: The launch of AI-centric exchange-traded funds (ETFs) has gained momentum, with over one-third of AI-themed ETFs introduced in 2024 alone, collectively managing assets worth $4.5 billion. This trend indicates growing investor interest in AI-driven investment opportunities.

Browse In-depth Market Research Report –https://www.marketresearchfuture.com/reports/ai-in-asset-management-market-26543

Regional Analysis:

Geographically, the adoption of AI in asset management varies:

North America: Leading the market with a significant share, North America’s dominance is attributed to advanced technological infrastructure, substantial investments in AI research, and the presence of major financial institutions. The region accounted for over 50% of the global AI in asset management market revenue in 2022.

Europe: European asset managers are increasingly integrating AI to enhance investment strategies and operational efficiency. The region’s regulatory environment supports innovation, and there is a strong emphasis on ethical AI deployment.

Asia-Pacific: This region is experiencing rapid growth in AI adoption within asset management, driven by technological advancements and a burgeoning fintech ecosystem. Countries like China, Japan, and India are at the forefront, leveraging AI for enhanced financial services. Asia-Pacific is anticipated to showcase significant growth with the fastest CAGR in the upcoming period.

Explore MRFR’s Related Ongoing Coverage In ICT Domain:

Panel Level Packaging Market –https://www.marketresearchfuture.com/reports/panel-level-packaging-market-43045

Passive Optical Network Pon Equipment Market –https://www.marketresearchfuture.com/reports/passive-optical-network-equipment-market-43004

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Media Contact
Company Name: Market Research Future
Contact Person: Media Relations
Email: Send Email
Country: United States
Website: https://www.marketresearchfuture.com

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: AI in Asset Management Market Poised to Reach USD 920.51 Billion, Expanding at a 26.92% CAGR by 2034

Emphysema Market Expected to rise, 2032 | Mereo BioPharma, United Therapeutics, GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Pfizer, Mylan, Novartis, expected to drive market

“Emphysema Market Expected to rise 2032, DelveInsight”
The Emphysema market growth is driven by factors like increase in the prevalence of Emphysema, investments in research and development, entry of emerging therapies during the study period 2019-2032.

The Emphysema market report also offers comprehensive insights into the Emphysema market size, share, Emphysema epidemiology, emerging therapies, market drivers and barriers, ongoing clinical trials, key collaboration in the space, market uptake by key therapies and companies actively pushing Emphysema market size growth forward.

Some of the key highlights from the Emphysema Market Insights Report:

  • In early 2024, the FDA expanded the use of Dupixent, developed by Regeneron Pharmaceuticals and Sanofi, to include chronic obstructive pulmonary disease (COPD), which encompasses emphysema. This marks the first targeted biological therapy approved for COPD. Clinical trials demonstrated that Dupixent reduced moderate-to-severe exacerbations by 30% over 52 weeks and improved lung function, with a favorable safety profile. ​

  • In June 2024, Verona Pharma’s Ohtuvayre received FDA approval as the first inhaled therapy with a novel mechanism of action for COPD in over two decades. Ohtuvayre is a dual inhibitor of the phosphodiesterase 3 and 4 enzymes, offering both bronchodilation and anti-inflammatory effects. Phase 3 trials showed significant improvements in lung function and a 40% reduction in exacerbations over 24 weeks in patients with moderate to severe COPD. ​

  • Olympus Corporation expanded the availability of its Spiration Valve System in March 2022. This minimally invasive device reduces lung hyperinflation in emphysema patients, leading to improved breathing and quality of life. ​

  • According to DelveInsight, the Emphysema Market is projected to grow at a strong rate from 2023 to 2032, driven by the introduction of new therapies and an increasing number of cases.

  • Several leading pharmaceutical and biotechnology companies, including Mereo BioPharma, United Therapeutics, GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Pfizer, Mylan, and Novartis, are actively engaged in advancing treatments for emphysema.

  • As per DelveInsight analysis, the Emphysema market is anticipated to witness growth at a considerable CAGR

Strategise your business goals by understanding market dynamics @ Emphysema Market Landscape

Emphysema Overview

Emphysema is a chronic lung disease that falls under chronic obstructive pulmonary disease (COPD). It causes damage to the air sacs (alveoli) in the lungs, making it difficult to breathe. Over time, the walls of the alveoli weaken and rupture, reducing the surface area available for oxygen exchange. This leads to shortness of breath, coughing, and wheezing.

Do you know the treatment paradigms for different countries? Download our Emphysema Market Sample Report

Emphysema Epidemiology Insights

  • Emphysema is a chronic lung condition characterized by the destruction of alveoli, leading to impaired gas exchange. It is a major component of chronic obstructive pulmonary disease (COPD) and is primarily associated with smoking and environmental pollutants. Here’s an overview of its epidemiology:

  • The Global Burden of Disease (GBD) Study estimates that COPD affects approximately 10–12% of the world’s population over 40 years of age.

Emphysema Epidemiology Segmentation

DelveInsight’s Emphysema market report is prepared on the basis of epidemiology model. It offers comprehensive insights to the Emphysema historical patient pools and forecasted Emphysema patients. The report provides in-depth data of various subtypes and for the same epidemiology is segmented further. The Emphysema Market report proffers epidemiological analysis for the study period 2019-32 in the 7MM segmented into:

  • Emphysema Prevalence

  • Age-Specific Emphysema Prevalence

  • Gender-Specific Emphysema Prevalence

  • Diagnosed and Treatable Cases of Emphysema

Visit for more @ Emphysema Epidemiological Insights

Emphysema Market Outlook

​The emphysema market is poised for significant growth from 2023 to 2032, driven by the rising prevalence of the disease and the introduction of innovative therapies.​

Key Emphysema Market Drivers

  • Increasing Prevalence: Factors such as aging populations and rising smoking rates contribute to a higher incidence of emphysema.​

  • Therapeutic Advancements: Ongoing research and development efforts are leading to the introduction of novel treatments, including regenerative therapies and advanced inhalation devices.​

  • Awareness and Diagnosis: Improved awareness and diagnostic techniques are facilitating earlier detection and intervention.

Emphysema Key Companies

  • Mereo BioPharma, United Therapeutics, GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Pfizer, Mylan, Novartis, and others

For more information, visit Emphysema Market Analysis, Patient Pool, and Emerging Therapies

Scope of the Emphysema Market Report:

  • 11 Years Forecast

  • 7MM Coverage

  • Descriptive overview of Emphysema, causes, signs and symptoms, diagnosis, treatment

  • Comprehensive insight into Emphysema epidemiology in the 7MM

  • Emphysema marketed and emerging therapies

  • Emphysema companies

  • Emphysema market drivers and barriers

Table of Contents:

1 Emphysema Market Key Comprehensive Insights

2 Emphysema Market Report Introduction

3 Competitive Intelligence Analysis for Emphysema

4 Emphysema Market Analysis Overview at a Glance

5 Executive Summary of Emphysema

6 Emphysema Epidemiology and Market Methodology

7 Emphysema Epidemiology and Patient Population

8 Emphysema Patient Journey

9 Emphysema Treatment Algorithm, Emphysema Current Treatment, and Medical Practices

10 Key Endpoints in Emphysema Clinical Trials

11 Emphysema Marketed Therapies

12 Emphysema Emerging Therapies

13 Emphysema: 7 Major Market Analysis

14 Attribute analysis

15 Access and Reimbursement Overview of Emphysema

16 Emphysema Market Key Opinion Leaders Reviews

18 Emphysema Market Drivers

19 Emphysema Market Barriers

20 SWOT Analysis

21 Disclaimer

22 DelveInsight Capabilities

23 About DelveInsight

Related Reports:

Emphysema Epidemiology 2032

DelveInsight’s “Emphysema – Epidemiology Forecast to 2032” report delivers an in-depth understanding of the disease, historical and forecasted Emphysema epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Emphysema Pipeline 2024

“Emphysema Pipeline Insights, 2024” report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Emphysema market. A detailed picture of the Emphysema pipeline landscape is provided, which includes the disease overview and Emphysema treatment guidelines.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Emphysema Market Expected to rise, 2032 | Mereo BioPharma, United Therapeutics, GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Pfizer, Mylan, Novartis, expected to drive market